NEUROSAGENA Trademark

Trademark Overview

On Monday, October 12, 2020, a trademark application was filed for NEUROSAGENA with the United States Patent and Trademark Office. The USPTO has given the NEUROSAGENA trademark a serial number of 79303379. The federal status of this trademark filing is REGISTERED as of Tuesday, April 26, 2022. This trademark is owned by Biogena GmbH & Co KG. The NEUROSAGENA trademark is filed in the Pharmaceutical Products category with the following description:

Nutritional supplements for medical purposes, namely, vitamin B nutritional supplements intended for consumption all aforementioned goods not in the field of beauty and/or skin health
neurosagena

General Information

Serial Number79303379
Word MarkNEUROSAGENA
Filing DateMonday, October 12, 2020
Status700 - REGISTERED
Status DateTuesday, April 26, 2022
Registration Number6708960
Registration DateTuesday, April 26, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 11, 2022

Trademark Statements

Goods and ServicesNutritional supplements for medical purposes, namely, vitamin B nutritional supplements intended for consumption all aforementioned goods not in the field of beauty and/or skin health

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, February 8, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBiogena GmbH & Co KG
Party Type30 - Original Registrant
Legal Entity Type28 - NOT AVAILABLE
AddressAT
Party NameBiogena GmbH & Co KG
Party Type20 - Owner at Publication
Legal Entity Type28 - NOT AVAILABLE
AddressAT
Party NameBiogena GmbH & Co KG
Party Type10 - Original Applicant
Legal Entity Type28 - NOT AVAILABLE
AddressAT

Trademark Events

Event DateEvent Description
Monday, September 26, 2022FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, September 1, 2022FINAL DISPOSITION NOTICE SENT TO IB
Thursday, September 1, 2022FINAL DISPOSITION PROCESSED
Tuesday, July 26, 2022FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, April 26, 2022REGISTERED-PRINCIPAL REGISTER
Wednesday, March 23, 2022EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Monday, February 28, 2022LIMITATION FROM THE IB - REQUEST EXAM REVIEW
Wednesday, February 2, 2022EXTENSION OF TIME TO OPPOSE RECEIVED
Friday, January 21, 2022LIMITATION OF GOODS RECEIVED FROM IB
Tuesday, January 11, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 11, 2022PUBLISHED FOR OPPOSITION
Monday, January 10, 2022NOTIFICATION PROCESSED BY IB
Wednesday, December 22, 2021NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, December 22, 2021NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, December 22, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, December 3, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, December 3, 2021LETTER OF PROTEST EVIDENCE REVIEWED-NO FURTHER ACTION TAKEN
Wednesday, September 15, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, September 14, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, September 14, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, August 20, 2021LETTER OF PROTEST EVIDENCE FORWARDED
Monday, April 5, 2021REFUSAL PROCESSED BY IB
Thursday, March 18, 2021NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, March 18, 2021REFUSAL PROCESSED BY MPU
Saturday, March 13, 2021NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, March 12, 2021NON-FINAL ACTION WRITTEN
Thursday, March 11, 2021ASSIGNED TO EXAMINER
Friday, February 12, 2021APPLICATION FILING RECEIPT MAILED
Monday, February 8, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, February 4, 2021SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

neurosagena nutritional supplements field goods skin health aforementioned beauty intended medical